The healthcare landscape is witnessing a remarkable surge in the global intraosseous infusion devices industry demand is poised to escalate from its current value of US$ 4.4 billion in 2023 to an estimated US$ 8.6 billion by 2033. This exponential growth trajectory indicates a robust Compound Annual Growth Rate (CAGR) of 6.9% throughout the forecast …
Category Archives: Healthcare Trends
Global Balloon Catheter Industry is on track to achieve an extraordinary worth of US$ 6.4 Billion by 2033 | says FMI
The global balloon catheter industry size is set to experience remarkable expansion over the next decade, following a projected CAGR of 4.3%. Reports indicate that the market revenue, currently at US$ 4.2 billion in 2023, is poised to soar significantly, reaching a staggering US$ 6.4 billion by 2033. This prediction is based on comprehensive market …
Global Special Purpose Needles Industry is expected to witness a robust surge, achieving US$ 27.0 billion by 2032 | FMI
The global special purpose needles industry is poised for substantial growth, projected to reach a valuation of US$ 12.6 Billion by the close of 2022. An extensive analysis foresees an impressive Compound Annual Growth Rate (CAGR) of 7.9% from 2022 to 2032, propelling the market to an estimated worth of US$ 27.0 Billion by 2032. …
Global Industrial Microbiology Industry is slated to attain US$ 32.12 Billion by 2033, powered by a substantial 7.6% CAGR | FMI
The global industrial microbiology industry has achieved a staggering valuation of US$ 15.49 billion in 2023, marking a significant milestone in the industry’s growth trajectory. With a projected compound annual growth rate (CAGR) of 7.6% from 2023 to 2033, the market is poised to escalate to a remarkable US$ 32.12 billion by 2033. The market’s …
Global Saudi Arabia Pharmaceutical Industry is projected to reach US$ 13,000 Million by the growth until 2032, according to FMI’s analysis
The global saudi arabia pharmaceutical industry is predicted to be worth US$ 13,000 Million by the end of 2032 to grow at an incredible 9.6% CAGR from 2022 to 2032, which will present a significant opportunity. The market is anticipated to be worth US$ 5,209.5 million by the end of 2022. Due to the country’s …
Global Platelet Rich Plasma Industry is expected to reach US$ 746.09 Billion by 2033 at a CAGR of 6% | FMI
The global platelet-rich plasma industry continues to soar, with estimations pegging its value at an impressive US$ 416.61 billion in 2023. Projections indicate a robust upward trajectory, foreseeing the market to surge to US$ 746.09 billion by 2033, boasting a noteworthy Compound Annual Growth Rate (CAGR) of 6% during the forecast period. Platelet-rich plasma (PRP) …
Global Revision Knee Replacement Industry Poised to Reach US$2 Billion by 2032 with a Remarkable 4.1% CAGR | Unveils FMI Insights
The Global Revision Knee Replacement Industry is set to witness a remarkable surge, with projections indicating a substantial leap from the current valuation of US$1.3 billion in 2022 to an anticipated US$2 billion by 2032. This robust growth is underscored by a compound annual growth rate (CAGR) of 4.1%, reflecting the market’s resilience and potential. Revision knee …
Global Kidney Stone Extraction Balloon Industry Poised for a Meteoric Rise to US$902.2 Million by 2032, Sustained by a Robust 6.5% CAGR | FMI
The Global Kidney Stone Extraction Balloon Industry is set to soar, projecting a robust 6.5% Compound Annual Growth Rate (CAGR) from 2022 to 2032. Starting at US$ 450.5 million in 2022, the industry is expected to reach a staggering US$ 902.2 million by 2032. This remarkable growth is primarily driven by the escalating incidence of kidney stones, …
Global MRI-Safe CRT Devices Industry on Track for 9.6% CAGR Ascendancy, Set to Hit US$ 1511 Million by 2032 | FMI
The Global MRI-Safe CRT Devices Industry which was worth US$ 550.5 million in 2022, is estimated to be worth US$ 1511 million by 2032, growing at a CAGR of 9.6% during the forecast period. Increasing incidences of heart failure, which leads to increased hospitalizations, as well as a variety of other issues, are projected to drive up demand for MRI-safe CRT systems. Global …
Global Airway Disease Treatment Industry on Track for Exceptional $3,495.3 Million Revenue by 2032 | FMI
The Global Airway Disease Treatment Industry is projected to amass a revenue of around US$ 3,495.3 million by 2032, up from US$ 1,996.1 million in 2022 moving forward with a CAGR of 5.2% during the forecast period. LABA-ICS, LAMA-ICS, triple treatment, and other related drugs are among the pharmaceuticals used in combination therapy for COPD. Combination therapy is gaining popularity due to its greater efficacy …